VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2013 SESSION

• history | hilite | pdf | print version

13104382D
HOUSE BILL NO. 2030 AMENDMENT IN THE NATURE OF A SUBSTITUTE (Proposed by the House Committee on Commerce and Labor on January 31, 2013) (Patron Prior to Substitute--Delegate Peace) A BILL to require the Virginia Department of Health to develop guidelines regarding patient assistance programs for specialty drug needs.

Be it enacted by the General Assembly of Virginia:

1. § 1. That the Virginia Department of Health, in consultation with the Bureau of Insurance of the State Corporation Commission, shall develop guidelines based on recommendations from representatives of interested entities and such other persons as the Department deems appropriate who shall develop, and provide to the Department, recommendations regarding (i) the availability and establishment of patient assistance programs for specialty drug needs in the Commonwealth; (ii) current resources available for such patient assistance programs and the level of resources needed to maximize existing programs; (iii) the implications of limiting the authority of health insurers to move a drug to a higher cost-sharing tier or otherwise modify prescription drug coverage without notifying the insureds and requiring that modifications be effective on a uniform basis; and (iv) opportunities to establish a specialty-tier safety net based on a collaborative public private partnership including but not limited to the Commonwealth and its pharmaceutical, and insurance, pharmacy benefit manager, specialty pharmacy, and patient advocacy partners.

2.  That the Virginia Department of Health shall submit a report to the Chairmen of the House Committee on Commerce and Labor, the Senate Committee on Commerce and Labor, the House Committee on Health, Welfare, and Institutions, the Senate Committee on Education and Health, the House Committee on Appropriations, and the Senate Committee on Finance not later than December 1, 2013, on the guidelines developed pursuant to the first enactment of this act.